GSK 2021 Investor Update: New Ambitions Strategy

GSK presented strategic ambitions for 2021-2026, targeting over 5% sales CAGR and 10% adjusted operating profit CAGR. The company prioritizes Vaccines and Specialty Medicines, optimizing its General Medicines portfolio while maintaining a progressive dividend policy and strengthening its balance sheet to support growth investments.